JP2011505164A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505164A5
JP2011505164A5 JP2010537075A JP2010537075A JP2011505164A5 JP 2011505164 A5 JP2011505164 A5 JP 2011505164A5 JP 2010537075 A JP2010537075 A JP 2010537075A JP 2010537075 A JP2010537075 A JP 2010537075A JP 2011505164 A5 JP2011505164 A5 JP 2011505164A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
protein
mature
elastase
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537075A
Other languages
English (en)
Japanese (ja)
Other versions
JP5829808B2 (ja
JP2011505164A (ja
Filing date
Publication date
Priority claimed from US12/327,809 external-priority patent/US8501449B2/en
Application filed filed Critical
Publication of JP2011505164A publication Critical patent/JP2011505164A/ja
Publication of JP2011505164A5 publication Critical patent/JP2011505164A5/ja
Application granted granted Critical
Publication of JP5829808B2 publication Critical patent/JP5829808B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537075A 2007-12-04 2008-12-04 組換えエラスターゼタンパク質ならびにその製造方法および使用 Expired - Fee Related JP5829808B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99231907P 2007-12-04 2007-12-04
US60/992,319 2007-12-04
US12/327,809 US8501449B2 (en) 2007-12-04 2008-12-03 Recombinant elastase proteins and methods of manufacturing and use thereof
US12/327,809 2008-12-03
PCT/US2008/085559 WO2009079220A2 (en) 2007-12-04 2008-12-04 Recombinant elastase proteins and methods of manufacturing and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015094887A Division JP6084653B2 (ja) 2007-12-04 2015-05-07 組換えエラスターゼタンパク質ならびにその製造方法および使用

Publications (3)

Publication Number Publication Date
JP2011505164A JP2011505164A (ja) 2011-02-24
JP2011505164A5 true JP2011505164A5 (https=) 2012-01-26
JP5829808B2 JP5829808B2 (ja) 2015-12-09

Family

ID=40344763

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010537075A Expired - Fee Related JP5829808B2 (ja) 2007-12-04 2008-12-04 組換えエラスターゼタンパク質ならびにその製造方法および使用
JP2015094887A Expired - Fee Related JP6084653B2 (ja) 2007-12-04 2015-05-07 組換えエラスターゼタンパク質ならびにその製造方法および使用
JP2017011160A Pending JP2017104114A (ja) 2007-12-04 2017-01-25 組換えエラスターゼタンパク質ならびにその製造方法および使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015094887A Expired - Fee Related JP6084653B2 (ja) 2007-12-04 2015-05-07 組換えエラスターゼタンパク質ならびにその製造方法および使用
JP2017011160A Pending JP2017104114A (ja) 2007-12-04 2017-01-25 組換えエラスターゼタンパク質ならびにその製造方法および使用

Country Status (25)

Country Link
US (14) US8501449B2 (https=)
EP (3) EP2666854B1 (https=)
JP (3) JP5829808B2 (https=)
KR (3) KR101732190B1 (https=)
CN (4) CN101918547B (https=)
AR (1) AR069584A1 (https=)
AU (1) AU2008338743B2 (https=)
BR (1) BRPI0819977A2 (https=)
CA (1) CA2707051C (https=)
CY (2) CY1114724T1 (https=)
DK (2) DK2666854T3 (https=)
ES (2) ES2436783T3 (https=)
HR (2) HRP20131135T1 (https=)
HU (1) HUE032739T2 (https=)
IL (2) IL206157A (https=)
LT (1) LT2666854T (https=)
MX (2) MX2010006211A (https=)
NZ (2) NZ585866A (https=)
PL (2) PL2229440T3 (https=)
PT (2) PT2666854T (https=)
RS (2) RS53083B (https=)
RU (1) RU2611200C2 (https=)
SI (2) SI2229440T1 (https=)
TW (2) TWI577385B (https=)
WO (1) WO2009079220A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501449B2 (en) 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
CN102250863B (zh) * 2011-04-29 2012-12-05 天津金斯坦生物科技有限公司 基因重组人中性粒细胞弹性蛋白酶及其制备方法和该弹性蛋白酶的医药用途
CA2905180C (en) 2013-03-15 2023-03-07 Alder Biopharmaceuticals, Inc. Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
US10202630B2 (en) * 2013-03-15 2019-02-12 Alderbio Holdings Llc Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
KR102486713B1 (ko) * 2017-03-10 2023-01-10 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
CA3066738A1 (en) * 2017-06-15 2018-12-20 The University Of Chicago Methods and compositions for treating cancer
WO2021108302A1 (en) * 2019-11-26 2021-06-03 Children's Hospital Medical Center Cela-1 inhibition for treatment of lung disease
WO2021146233A1 (en) * 2020-01-14 2021-07-22 Basf Se Method for producing recombinant protein in yeast cells
CN116261592A (zh) * 2020-08-18 2023-06-13 昂希莱斯制药公司 经修饰的丝氨酸蛋白酶前蛋白
US12516307B2 (en) 2020-08-18 2026-01-06 Onchilles Pharma, Inc. Modified porcine pancreatic elastase proteins

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2508408A (en) 1943-10-11 1950-05-23 Sidney H Liebson Averaging indicator
US2546308A (en) 1948-12-29 1951-03-27 Kahler John Floor marking device
US5212068A (en) * 1985-04-05 1993-05-18 Sankyo Company Limited Human pancreatic elastase
DE122007000007I2 (de) 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
JPH0673456B2 (ja) * 1986-04-26 1994-09-21 三共株式会社 ヒト・膵臓エラスタ−ゼ▲i▼
US5162205A (en) 1986-04-26 1992-11-10 Sankyo Company, Limited Human pancreatic elastase I
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5543302A (en) * 1988-05-27 1996-08-06 Solvay Enzymes, Inc. Proteases of altered stability to autolytic degradation
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
EP0945515A3 (en) 1989-11-06 2002-08-21 Cell Genesys, Inc. Production of proteins using homologous recombination
GB8927722D0 (en) 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
US5503333A (en) * 1993-06-23 1996-04-02 Laventure; David Duster extension tube system with dust collecting region and tube cleaner and method of using the same
US5811252A (en) * 1994-07-07 1998-09-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Modified proenzymes as substrates for proteolytic enzymes
US5955072A (en) * 1994-07-13 1999-09-21 Sankyo Company, Limited Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
US7531325B2 (en) * 1997-04-25 2009-05-12 Sembiosys Genetics Inc. Method for cleavage of fusion proteins
US20030207402A1 (en) * 1997-08-22 2003-11-06 Erhard Kopetzki Autocatalytically activatable zymogenic precursors of proteases and their use
GB9817909D0 (en) * 1998-08-17 1998-10-14 Zeneca Ltd DNA constructs
GB9908458D0 (en) 1999-04-13 1999-06-09 Queen Mary & Westfield College Enzyme
WO2000068363A2 (en) 1999-05-05 2000-11-16 Genentech, Inc. Elastase variants and substrates
US7001892B1 (en) * 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
AU7612100A (en) * 1999-09-24 2001-04-24 Johns Hopkins University, The Systems and methods for opening obstructed biological conduits
US7063838B1 (en) * 1999-09-24 2006-06-20 Proteon Therapeutics Llc Methods for treating an artery or vein in a human subject
US7351549B2 (en) * 2000-01-24 2008-04-01 Polymun Scientific Immunbiologische Forschung Gmbh Method for the manufacture of recombinant trypsin
AU4329001A (en) * 2000-02-24 2001-09-03 Compound Therapeutics, Inc. Improved methods for generating catalytic proteins
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060189941A1 (en) 2002-01-22 2006-08-24 Mercator Medsystems, Inc. Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation
AU2004213050B2 (en) 2003-02-20 2010-09-09 Proteon Therapeutics, Inc. Methods for the treatment and prevention of diseases of biological conduits
US7571008B2 (en) 2003-08-18 2009-08-04 Medtronic, Inc. System and apparatus for remote activation of implantable medical devices
JP2008503712A (ja) * 2004-06-21 2008-02-07 ガラパゴス・ナムローゼ・フェンノートシャップ 骨関節炎治療の方法及び手段
BRPI0515569A (pt) 2004-09-22 2008-07-29 Proteon Therapeutics Inc métodos para reduzir vasospasmo em um segmento de um conduto biológico, para reduzir a capacidade de um vaso sofrer vasospasmo em um segmento de um conduto biológico e para reduzir o acúmulo de hiperplasia ìntima em um segmento de um conduto biológico
RU2299070C2 (ru) * 2005-02-08 2007-05-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения заболевания вен и способ ее получения
US20060193824A1 (en) * 2005-02-28 2006-08-31 Rubin Bruce K Methods for the treatment of infectious and inflammatory airway diseases
CN1769424A (zh) * 2005-09-20 2006-05-10 浙江大学 一种芽孢杆菌菌株及其用途
SG175602A1 (en) * 2006-07-05 2011-11-28 Catalyst Biosciences Inc Protease screening methods and proteases identified thereby
US8501449B2 (en) 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
PT2271767T (pt) * 2008-04-03 2016-08-18 Cb Biotechnologies Inc Reação em cadeia de polimerase para captura de amplicões em multiplexo para amplificação de alvos múltiplos

Similar Documents

Publication Publication Date Title
JP2011505164A5 (https=)
JP6947888B2 (ja) クロストリジウム・ヒストリチクム(clostridium histolyticum)酵素およびその使用のための方法
AU2024266824A1 (en) Expression of FOXP3 in edited CD34+ cells
JP2014531910A5 (https=)
JP2016505539A5 (https=)
JP2011504366A5 (https=)
RU2010127232A (ru) Рекомбинантные белки эластазы и способы их получения и применения
CN104311671B (zh) 猫长效融合干扰素及其制备方法与应用
CN112552413B (zh) 新型冠状病毒重组蛋白亚单位疫苗
CN106279439A (zh) 一种含有穿膜肽的寡肽‑1融合蛋白及其制备方法
WO2025236842A1 (zh) 一种vzv重组蛋白及其制备方法和应用
CN102212539B (zh) 高效表达的串联猪α、γ干扰素基因及其表达蛋白的用途
CN102731658A (zh) 一种Tat PTD-Endostatin重组蛋白及其制备方法与应用
WO2013013602A1 (zh) 一种鸡干扰素γ的制备复性方法
CN115820578A (zh) 突变体组合物、融合酶及胶原三肽的制备方法
JP2002516662A5 (https=)
CN118146321B (zh) 一种rsv重组蛋白疫苗及其制备方法
CN121378514A (zh) 一种dhodh多肽降解剂及其在制备预防和/或治疗dhodh介导的疾病的药物中的应用
CN104292341B (zh) 一种凝血八因子融合蛋白及其制备方法和用途
JP2009507474A5 (https=)
CN114196691B (zh) 一种制备防治牛、羊棘球蚴病多表位重组疫苗的基因、蛋白质、疫苗和应用
CN101560247A (zh) 大肠杆菌热敏性肠毒素双突变体作为疫苗黏膜免疫佐剂
WO2016004904A2 (zh) 一种流感血凝素糖蛋白多聚物纳米颗粒的制备方法
CN103495159A (zh) 柱状黄杆菌基因重组疫苗的制备方法
CN114569707B (zh) 腺苷脱氨酶或其修饰物在制备糖尿病治疗药物中的应用